Announcement on Voluntary Disclosure of FDA Clinical Trial Approval for the Indication of YKYY018 Nebulized Inhalation for the Treatment and Prevention of Human Parainfluenza Virus Infection by Subsidiary

About this update from Youcare Pharmaceutical Group Co. Ltd. Class A

Announcement on Voluntary Disclosure of FDA Clinical Trial Approval for the Indication of YKYY018 Nebulized Inhalation for the Treatment and Prevention of Human Parainfluenza Virus Infection by Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Youcare Pharmaceutical Group Co. Ltd. Class A